Cargando…

Magnesium in Ketamine Administration in Treatment-Resistant Depression

Relationship between depression and magnesium levels is reported. This observational study examined whether serum magnesium concentration change over time of ketamine treatment course, also whether association between magnesium concentrations and treatment response measured with Montgomery-Åsberg De...

Descripción completa

Detalles Bibliográficos
Autores principales:	Górska, Natalia, Cubała, Wiesław Jerzy, Słupski, Jakub, Wiglusz, Mariusz Stanisław, Gałuszko-Węgielnik, Maria, Kawka, Mateusz, Grzegorzewska, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147622/ https://www.ncbi.nlm.nih.gov/pubmed/34063604 http://dx.doi.org/10.3390/ph14050430

Ejemplares similares

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2020)

Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
por: Cubała, Wiesław Jerzy, et al.
Publicado: (2010)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
por: Włodarczyk, Adam, et al.
Publicado: (2021)

Comment on ‘The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy’
por: Grzegorzewska, Agata M., et al.
Publicado: (2023)

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
por: Mechlińska, Agnieszka, et al.
Publicado: (2023)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
por: Wilkowska, Alina, et al.
Publicado: (2022)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Severe skin complications in patients treated with antidepressants: a literature review
por: Herstowska, Marta, et al.
Publicado: (2014)

Dysphoria and Irritability—Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Gut Microbiota in Depression: A Focus on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2021)

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis
por: Włodarczyk, Adam, et al.
Publicado: (2020)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten, Katarzyna, et al.
Publicado: (2016)

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
por: Wilkowska, Alina, et al.
Publicado: (2019)

Ketamine in Bipolar Disorder: A Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
por: Szałach, Łukasz Piotr, et al.
Publicado: (2022)

Dietary Patterns of Treatment–Resistant Depression Patients
por: Mechlińska, Agnieszka, et al.
Publicado: (2022)

The interactive effects of ketamine and magnesium upon depressive-like pathology
por: Razmjou, Sara, et al.
Publicado: (2016)

Heart rate variability and incidence of depression during the first six months following first myocardial infarction
por: Wilkowska, Alina, et al.
Publicado: (2019)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
por: Wichniak, Adam, et al.
Publicado: (2021)

Safety of Repeated Administration of Parenteral Ketamine for Depression
por: Feifel, David, et al.
Publicado: (2020)

Residual insomnia in major depressive disorder: a systematic review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Magnesium and Ketamine Gargle and Postoperative Sore Throat
por: Teymourian, Houman, et al.
Publicado: (2015)

Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?
por: Włodarczyk, Adam, et al.
Publicado: (2020)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Conjunctival administration of S+ketamine in rabbits
por: Hess, L, et al.
Publicado: (2013)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Ketamine versus Ketamine / magnesium Sulfate for Procedural Sedation and Analgesia in the Emergency Department: A Randomized Clinical Trial
por: Azizkhani, Reza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sarqf84ko8gca77i6fdnccfh8v